2348 fundamentals
DAWNRAYS PHARMACEUTICAL HLDGS financial statements, including revenue, expenses, and profit
The total revenue of 2348 for the last semiannual is 523.82 M HKD, and it's 16.29% lower compared to the previous semiannual. The net income of H2 24 is 77.99 M HKD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
TTM